Repirinast structure
|
Common Name | Repirinast | ||
---|---|---|---|---|
CAS Number | 73080-51-0 | Molecular Weight | 221.219 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 461.1±55.0 °C at 760 mmHg | |
Molecular Formula | C8H11N7O | Melting Point | 236-241° | |
MSDS | N/A | Flash Point | 232.6±31.5 °C |
Use of RepirinastRepirinast (MY-5116) is an orally active anti-allergic agent. Repirinast inhibits histamine release. Repirinast can be used in the research of bronchial asthma[1][2][3]. |
Name | 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylate |
---|---|
Synonym | More Synonyms |
Description | Repirinast (MY-5116) is an orally active anti-allergic agent. Repirinast inhibits histamine release. Repirinast can be used in the research of bronchial asthma[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Repirinast inhibits histamine release from rat peritoneal mast cells induced by antigen (IC50: 0.3 μM)[3]. |
In Vivo | Repirinast (30 mg/kg, i.p.) inhibits antigen-induced early and late pulmonary responses in guinea pigs[1]. Repirinast (30 mg/kg, p.o.) inhibits antigen-induced immediate bronchoconstriction in rats[2]. Animal Model: Guinea pigs[1] Dosage: 30 mg/kg Administration: Intraperitoneal injection (i.p.) Result: Inhibited leukocyte (predominantly eosinophils) infiltration into bronchial tissue. Blocked antigen-induced airway hyperresponsiveness to inhaled Acetylcholine. Animal Model: Rat with asthma (challenged with 10 mg/kg antigen OVA)[1] Dosage: 30 mg/kg Administration: Oral administration (p.o.) Result: Inhibited the decreases in the number Of breath at 30 sec and 1 min after challenge. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 461.1±55.0 °C at 760 mmHg |
Melting Point | 236-241° |
Molecular Formula | C8H11N7O |
Molecular Weight | 221.219 |
Flash Point | 232.6±31.5 °C |
Exact Mass | 221.102509 |
PSA | 89.37000 |
LogP | 0.46 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.731 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
HS Code | 2934999090 |
---|
~% Repirinast CAS#:73080-51-0 |
Literature: European Journal of Medicinal Chemistry, , vol. 16, # 3 p. 251 - 256 |
~% Repirinast CAS#:73080-51-0 |
Literature: European Journal of Medicinal Chemistry, , vol. 16, # 3 p. 251 - 256 |
~% Repirinast CAS#:73080-51-0 |
Literature: European Journal of Medicinal Chemistry, , vol. 16, # 3 p. 251 - 256 |
~% Repirinast CAS#:73080-51-0 |
Literature: European Journal of Medicinal Chemistry, , vol. 16, # 3 p. 251 - 256 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4H-pyrano(3,2-c)quinoline-2-carboxylate |
MY-5116 |
Repirinastum [INN-Latin] |
Diazenecarboxamide, 2-[4-[2-(diaminomethylene)hydrazinyl]phenyl]-, (E)- |
Romet |
Isopentyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4H-pyrano(3,2-c)quinoline-2-carboxylate |
(E)-2-{4-[2-(Diaminomethylene)hydrazino]phenyl}diazenecarboxamide |
repirinast |